Mark Cuban (Jed Jacobsohn/AP Images)
Moving to the employer side of healthcare, Mark Cuban's Cost Plus Drugs partners with a PBM
From “Shark Tank” to direct-to-consumer generic drugs, Mark Cuban has made another inroad in the ongoing battle over prescription drug prices. His cost-plus-15% generic drug …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
